Product Description
An updated and expanded edition of a highly lauded plan for preventing and fighting cancer through a macrobiotic natural-foods diet offers new cases, updates on the disease, inspirational advice, and delicious new recipes…. More >>
CTRC commences enrollment in Phase 2 trial of REOLYSIN combination for SCC lung cancer
A virus that destroys cancer cells but leaves normal cells unharmed may offer hope to those affected by squamous cell carcinoma of the lungs (SCC lung cancer), according to investigators from the Cancer Therapy & Research Center (CTRC) at the University of Texas Health Science Center at San Antonio. The CTRC has started patient enrollment in a US Phase 2 clinical trial using intravenous …
Read more on News-Medical-Net
Ovarian cancer is a silent killer and is one of the deadliest threats to women’s health. The American Cancer Society says that about 20,180 American women will be diagnosed with ovarian cancer this year alone. Every woman faces a risk of 1:57 risk of getting ovarian cancer in her lifetime.
The symptoms of ovarian cancer are not perceptible until the cancer becomes widespread and critical, which explains why thousands of women die of this dreaded disease every year. Although ovarian cancer is treatable, in most instances, it is detected late causing complications and death to ovarian cancer patients.
» Read more: Ovarian Cancer Research